| Title |
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial
|
|---|---|
| Published in |
Trials, November 2020
|
| DOI | 10.1186/s13063-020-04864-4 |
| Pubmed ID | |
| Authors |
Emanuele Bosi, Carlo Bosi, Patrizia Rovere Querini, Nicasio Mancini, Giliola Calori, Annalisa Ruggeri, Cecilia Canzonieri, Luciano Callegaro, Massimo Clementi, Francesco De Cobelli, Massimo Filippi, Marco Bregni |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 1 | 20% |
| Unknown | 4 | 80% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Scientists | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 183 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 23 | 13% |
| Researcher | 15 | 8% |
| Student > Master | 12 | 7% |
| Student > Doctoral Student | 11 | 6% |
| Other | 9 | 5% |
| Other | 23 | 13% |
| Unknown | 90 | 49% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 15% |
| Nursing and Health Professions | 19 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 9% |
| Engineering | 6 | 3% |
| Economics, Econometrics and Finance | 3 | 2% |
| Other | 19 | 10% |
| Unknown | 92 | 50% |